We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 0.65% | 234.00 | 233.00 | 233.50 | 234.50 | 227.50 | 227.50 | 290,479 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 23.75M | -50.35M | -0.1839 | -12.70 | 639.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/8/2020 10:08 | if prtc follows same flight path, vedanta could be half of market cap in short order! here's hoping! | edwardt | |
11/8/2020 08:19 | for those not in the know vedanta is phase 2 for microbiome product for c diff reinfection risk. we are all looking at karuna - prtc has multiple moon shots. this one could be the next. | edwardt | |
11/8/2020 08:17 | good readacross from seres on c difficile phase 3 results. even by my duff maths a move of $4 to $22 overnight is life changing for investors! | edwardt | |
07/8/2020 08:40 | Karuna now below $84 | zipstuck | |
29/7/2020 10:20 | rogers, I liked this stock and its cash pile, with the added side show of the listed Karuna...it became apparent when the directors took their share options in cash after a raft of good news to bolster the price first, at that stage it wasn't for me. Still has plenty going on, like Karuna, Vedanta, Vor and its own pipeline could come good, but Akili can be copied, Gelesis run by Mrs Zohar's husband could point to Plenity being a diet fad, maybe a winner who knows, wasn't over keen either on the hair restorer and tropical scrub etc. Anyhow good luck to all, as with all biotech, 1 blockbuster can change everything. Ready to reinvest if the outlook changes. | volvo | |
29/7/2020 08:40 | Volvo, always interesting keep the chats coming. | rogers49 | |
29/7/2020 08:25 | Well it was a smart move by the directors to cash in some Karuna shares ($350m) to fund their own pipeline of drugs and of course their expensive salaries, share options, pensions etc. Karuna down $30 from its recent highs to $85, each dollar equates to approx $5m, so $150m down in a month. | volvo | |
24/7/2020 21:08 | Fat profits aplenity for Gelesis! Sheltering in place has led to serious weight gain of up to 16 pounds for 76 percent of Americans, says a new study commissioned by Nutrisystem, a commercial weight- loss product and service provider. Another 63 percent of U.S. adults admitted they are now prioritizing post-quarantine weight loss to counteract the dietary choices they have made during the coronavirus lockdowns, which began in mid-March. Other difficulties the survey highlighted were that 42 percent of Americans have been struggling to stay physically active and maintain a consistent meal schedule while 34 percent are having a hard time staying motivated while they work from home. | rambutan2 | |
20/7/2020 07:41 | I still hold here. There have been a number of positive announcements since the company bought directors options. The company were in the know and the directors would not have wanted to sell options at discount. Always more risk on pharma's but then rewards are there. | zipstuck | |
17/7/2020 07:26 | ....Probably Jupiter asked for a leg up to shift some stock, who knows. | volvo | |
14/7/2020 07:50 | The compelling investment case at 240p was the cash pile and Karuna shares....together they amounted to roughly the share value so you got all the 'fads' and a few serious drugs for free. Karuna closed yesterday at $90...it was $115 just a few weeks ago, and we know cash burn is high. I also didnt like the management taking the share options in cash. As for the Sunday Times tip, I normally run a mile from those things. Probably Jupiter asked for a leg up to shift some stock, who knows. I sold last week at 289p and taken a watching brief. | volvo | |
14/7/2020 07:42 | Karuna down to $90 | zipstuck | |
14/7/2020 07:29 | Theoretically it should be one of those shares that is significantly higher during Covid19 pandemic them before. | netcurtains | |
14/7/2020 00:19 | Buy it at 260, sell it at 290 | lendmeafiver | |
13/7/2020 23:24 | Ha ha ha. What are your thoughts lendmeafiver | paulman10 | |
13/7/2020 21:01 | Because you like investing in fads? | lendmeafiver | |
13/7/2020 20:53 | Gelesis weight gain drug looks like a fad Akili adhd game looks like a fad The company behind an app to test for coronovirus looks like a fad I've saw medical devices like these only last so long.... why should I invest in this company? | paulman10 | |
13/7/2020 20:35 | A sensible Volvo, it does look like this will stay in the 260 to 290 range for a while given the seller. Perhaps that’s why the bonuses where taken in cash at that price range. | lendmeafiver | |
13/7/2020 17:46 | ...not yet. Took 20pc uplift, after Karuna dropped to the 90's. Need to make a living. Ready to invest again, watching atm. | volvo | |
13/7/2020 12:24 | Back in Volvo? | lendmeafiver | |
13/7/2020 12:09 | true. above average volume though. i guess the seller is soaking it up but will surely the algorithmic trade will let it mover higher in face of retail flow. | edwardt | |
13/7/2020 10:44 | All buys being meet by the straight bat of a seller. | volvo | |
13/7/2020 08:25 | i cannot believe that article didn't capture the imagination. lets see where we finish but i suspect we might hit £3... | edwardt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions